In order to obtain this action we must pay 0,48$ right now, EyeGate Pharmaceuticals Inc, with address at 271 WAVERLEY OAKS ROAD SUITE 108, WALTHAM, Massachusetts, 2452, United States, is a publicly traded company and its visible heads at the moment are Brenda K. Mann (Vice President-Research & Development), Franz Obermayr (Chief Executive Officer), Lisa Brandano (Vice President-Clinical Operations), Sarah M. Romano (Chief Financial & Accounting Officer). Focused on Biotechnology: In Vitro & In Vivo Diagnostic Substances was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 0,47$ - 0,50$, with a percentage difference of 0,48$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
